Cowen and Company’s SomaLogic, Inc. Warrant SLGCW Stock Holding History

Cowen and Company’s Portfolio SLGCW Stock Details SLGCW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-467,501	Closed	-$56.1K	–	803
2023 Q4	$56.1K	Buy	+467,501	New	+$66.6K	﹤0.01%	270

Other funds holding SLGCW

Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Cowen and Company's SLGCW Position: Q1 2024 in Review

Cowen and Company sold out of SomaLogic, Inc. Warrant (SLGCW) in Q1 2024, closing a stake of 467,501 shares — an estimated $56.1K sold.

Cowen and Company first reported a position in SLGCW in Q4 2023 and held it in 1 quarter. The position peaked at $56.1K in Q4 2023. 4 funds tracked by Wall St. Rank hold SLGCW as of Q1 2024.

Cowen and Company reported no remaining SomaLogic, Inc. Warrant position as of Q1 2024 after selling out during the quarter.
Cowen and Company sold 467,501 SomaLogic, Inc. Warrant shares in Q1 2024, an estimated $56.1K.
Cowen and Company first reported a position in SomaLogic, Inc. Warrant in Q4 2023 and held it in 1 quarter.
Cowen and Company's SomaLogic, Inc. Warrant position peaked at $56.1K in Q4 2023.
4 funds tracked by Wall St. Rank held SomaLogic, Inc. Warrant as of Q1 2024.

Based on Cowen and Company's 13F filing for Q1 2024, filed 3 May 2024.